By Devika Patel
Knoxville, Tenn., May 1 – Vivus, Inc. plans to sell $110 million of 10.375% senior secured notes due 2024 in a private placement with funds managed Athyrium Capital Management LP, according to a press release.
The notes will be interest-only for the first three years.
Concurrently with the notes sale, Vivus will repurchase the $60 million of convertible notes held by funds managed by Athyrium at a discount to par.
The company also plans to restructure a portion of its corporate debt.
Mountain View, Calif.-based Vivus is a pharmaceutical company focused on treatments for obesity and sexual dysfunction.
| Issuer: | Vivus, Inc.
|
| Issue: | Senior secured notes
|
| Amount: | $110 million
|
| Maturity: | 2024
|
| Coupon: | 10.375%
|
| Investors: | Athyrium Capital Management LP
|
| Announced: | May 1
|
| Distribution: | Private placement
|
|
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
